Bicara Therapeutics Inc. (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

21.68

+0.84 (4.03%)

May 22, 2026, 4:00 PM EDT - Market closed

Bicara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	1,424	953	948	-	-
Market Cap Growth	98.93%	0.45%	-	-	-
Enterprise Value	886.15	538.38	458.77	0	0
Last Close Price	21.68	16.83	17.42	-	-
PB Ratio	2.76	2.37	1.93	-	-
P/TBV Ratio	2.37	2.29	0.60	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0
Net Debt / Equity Ratio	-1.05	-1.03	-0.99	1.55	0.04
Net Debt / EBITDA Ratio	3.10	2.66	5.94	5.76	0.11
Net Debt / FCF Ratio	4.62	3.86	6.54	4.97	0.13
Quick Ratio	13.72	14.33	27.22	15.28	0.17
Current Ratio	13.85	14.58	27.93	15.32	0.21
Return on Equity (ROE)	-34.37%	-30.88%	-19.14%	-51.67%	219.04%
Return on Assets (ROA)	-35.40%	-33.12%	-22.21%	-33.15%	-561.79%
Return on Invested Capital (ROIC)	968.39%	3567.57%	1977.41%	244.67%	176.37%
Return on Capital Employed (ROCE)	-37.99%	-34.81%	-23.18%	-39.55%	219.02%
Buyback Yield / Dilution	-85.90%	-225.35%	-2796.96%	-35.20%	-
Total Shareholder Return	-85.90%	-225.35%	-2796.96%	-35.20%	-

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q